When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
IMRN - FDA guides on development plans for Immuron's new oral therapeutic for gut-mediated pathogens
Immuron Limited
Immuron (NASDAQ:IMRN)surges 89% premarket after the Naval Medical Research Center (NMRC) received written FDA guidance in relation to the clinical development pathway of Company's new investigational drug being developed for the treatment of moderate to severe campylobacteriosis and Enterotoxigenic Escherichia coli infections.
More news on: Immuron Limited, Healthcare stocks news, Stocks on the move,